RADIANT_2A | R Documentation |
Kaplan-Meier digitized data from RADIANT, figure 2A (PMID 26324372). A reported sample size of 973 for a primary endpoint of DFS in lung cancer.
RADIANT_2A
A data frame of 973 observations and 3 variables:
time | event time (in months) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (erlotinib, placebo) | |
Kelly K, Altorki NK, Eberhardt WEE, et al. Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial. J Clin Oncol 2015; 33: 4007–14.
summary(RADIANT_2A)
kmplot(RADIANT_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.